Profound Medical Corp. (PRN.TO)
CAD 6.58
(-1.2%)
CAD 6.58
(-1.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.19 Million | 6.68 Million | 6.87 Million | 7.3 Million | 4.23 Million | 1.91 Million |
| Cost of Revenue | 2.81 Million | 3.66 Million | 3.92 Million | 3.83 Million | 1.8 Million | 1.3 Million |
| Gross Profit | 4.38 Million | 3.02 Million | 2.95 Million | 3.47 Million | 2.42 Million | 604.81 Thousand |
| Operating Expenses | 32.99 Million | 32.62 Million | 33.24 Million | 22.33 Million | 17.55 Million | 15.43 Million |
| Selling, General and Administrative Expenses | 18.62 Million | 17.93 Million | 17.96 Million | 12.42 Million | 8.01 Million | 7.89 Million |
| Research and Development Expenses | 14.37 Million | 14.69 Million | 15.27 Million | 9.91 Million | 9.54 Million | 7.53 Million |
| Other Expenses | - | - | - | - | - | 3755.42 |
| Cost and Expenses | 35.81 Million | 36.28 Million | 37.16 Million | 26.16 Million | 19.36 Million | 16.73 Million |
| Operating Income | -28.61 Million | -29.6 Million | -30.29 Million | -18.86 Million | -15.13 Million | -14.82 Million |
| Interest Expense | 770 Thousand | 174 Thousand | 303 Thousand | 543 Thousand | 544.74 Thousand | 755.37 Thousand |
| Income Tax Expense | -128 Thousand | 287 Thousand | 105 Thousand | 45 Thousand | 148.41 Thousand | 169.44 Thousand |
| Earnings before Tax | -28.69 Million | -28.38 Million | -30.59 Million | -21.57 Million | -15.3 Million | -15.07 Million |
| Net Income | -28.56 Million | -28.66 Million | -30.69 Million | -21.62 Million | -15.45 Million | -15.24 Million |
| Earnings Per Share Basic | -1.35 | -1.38 | -1.50 | -1.25 | -1.39 | -1.52 |
| Earnings Per Share Diluted | -1.35 | -1.38 | -1.50 | -1.25 | -1.39 | -1.52 |
| Weighted Average Shares Outstanding | 21.18 Million | 20.77 Million | 20.46 Million | 17.29 Million | 11.09 Million | 10.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.18 Million | 20.77 Million | 20.46 Million | 17.29 Million | 11.09 Million | 10.03 Million |
| Gross Margin | 0.61 | 0.45 | 0.43 | 0.48 | 0.57 | 0.32 |
| EBIT Margin | -3.72 | -3.81 | -4.13 | -2.28 | -3.12 | -6.93 |
| Profit Margin | -3.97 | -4.29 | -4.47 | -2.96 | -3.65 | -7.98 |
| EBITDA | -26.78 Million | -34.63 Million | -28.64 Million | -19.49 Million | -12.52 Million | -13.24 Million |
| Earnings Before Tax Margin | -3.97 | -4.43 | -4.41 | -2.58 | -3.58 | -7.76 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.23 Million | 1.91 Million | 2 Million | 7.19 Million | 1.72 Million | 1.6 Million |
| Cost of Revenue | 795 Thousand | 641 Thousand | 950 Thousand | 2.81 Million | 668 Thousand | 552 Thousand |
| Gross Profit | 1.43 Million | 1.26 Million | 1.05 Million | 4.38 Million | 1.06 Million | 1.05 Million |
| Operating Expenses | 9.27 Million | 8.75 Million | 9.84 Million | 32.99 Million | 7.62 Million | 7.48 Million |
| Selling, General and Administrative Expenses | 5.07 Million | 4.81 Million | 5.87 Million | - | 4.2 Million | 4.33 Million |
| Research and Development Expenses | 4.19 Million | 3.93 Million | 3.96 Million | - | 3.41 Million | 3.15 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 10.06 Million | 9.39 Million | 10.79 Million | 35.81 Million | 8.28 Million | 8.03 Million |
| Operating Income | 7.83 Million | -7.48 Million | -8.78 Million | -28.61 Million | -6.56 Million | 6.43 Million |
| Interest Expense | - | - | - | 770 Thousand | - | 192 Thousand |
| Income Tax Expense | 20 Thousand | 39 Thousand | -229 Thousand | -128 Thousand | 18 Thousand | 35 Thousand |
| Earnings before Tax | -6.89 Million | -6.16 Million | -9.13 Million | -28.69 Million | -5.54 Million | -7.32 Million |
| Net Income | -6.91 Million | -6.19 Million | -8.9 Million | -28.56 Million | -5.56 Million | -7.35 Million |
| Earnings Per Share Basic | -0.28 | -0.26 | -0.42 | - | -0.26 | -0.35 |
| Earnings Per Share Diluted | -0.28 | -0.26 | -0.42 | - | -0.26 | -0.35 |
| Weighted Average Shares Outstanding | 24.44 Million | 23.84 Million | 21.37 Million | 21.18 Million | 21.27 Million | 21.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.44 Million | 23.84 Million | 21.37 Million | 21.18 Million | 21.4 Million | 21.01 Million |
| Gross Margin | 0.64 | 0.66 | 0.53 | 0.61 | 0.61 | 0.66 |
| EBIT Margin | -3.38 | -3.76 | -3.88 | - | -3.63 | -3.84 |
| Profit Margin | -3.10 | -3.25 | -4.43 | -3.97 | -3.22 | -4.59 |
| EBITDA | -7.54 Million | -7.17 Million | -7.79 Million | - | -6.27 Million | -6.15 Million |
| Earnings Before Tax Margin | 3.51 | -3.92 | -4.37 | -3.97 | -3.80 | 4.02 |
7360
603421
HBIO
PERI
CYC
BAC-PM